Navigation Links
LIAI researchers discover new cellular mechanism that will significantly advance vaccine development
Date:6/16/2008

SAN DIEGO (June 16, 2008) La Jolla Institute for Allergy & Immunology (LIAI) scientists have discovered one for the textbooks. Their finding, reported Friday in the scientific journal Immunity, illuminates a new, previously unknown mechanism in how the body fights a virus. The finding runs counter to traditional scientific understanding of this process and will provide scientists a more effective method for developing vaccines.

"Our research grew from the question, "why do you get good antibody responses to some parts of (virus) pathogens and poor responses to other parts?" said LIAI scientist Shane Crotty, Ph.D., the lead researcher on the paper, "Selective CD4 T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities." Alessandro Sette, Ph.D., a renowned vaccine expert and director of the LIAI Center for Infectious Disease, also was a key contributor on the study. Dr. Crotty said the team studied the smallpox vaccine, considered the "gold standard" of vaccines, and found some startling answers.

"We expected one thing based on textbook knowledge and that didn't happen at all," he said. It was known previously that getting a good antibody response requires two different cells of the immune system -- B cells and CD4 T cells, both soldiers in the immune system's defensive army. Antibody responses are important because they help the body fight off viruses and they also are key to vaccine development. Surprisingly, however, Dr. Crotty said the researchers found that B cells and CD4 T cells recognize the same piece of the virus.

"Previously, it was thought that the CD4 T cell could react to any part of the virus, but now we realize it must be specific to the same part as the B cell," he explained. "When you have a hundred different parts, this knowledge makes a big difference. It narrows down the search for the right antigens tremendously."

Scientists use knowledge of which antigens (virus pieces) trigger an antibody attack to develop vaccines. Vaccines work by exposing the individual to a milder form of a particular virus, so that the body makes antibodies to fight off the virus. Consequently, if the individual is later exposed to the actual virus, the body already has an army of antibodies built up that can fight off this stronger viral attack before it can overtake the body and cause sickness.

With the knowledge gained from the LIAI study, scientists will now be able to more easily figure out the most important viral pieces to focus on in developing a vaccine. "The fact that it requires two components to fight the (virus) pathogen is important to understand," Dr. Crotty said. "So now when we find out which viral pieces are producing a strong response from the B cells, we can cross check that against the viral pieces eliciting a good response from the CD4 T cells. The point at which these virus pieces cross in other words where the same piece is eliciting a response from both the B cells and CD4 T cells then we know we have found our best candidate for creating a vaccine."


'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Related biology news :

1. Stem cell researchers give old muscle new pep
2. UT Southwestern researchers create molecule that nudges nerve stem cells to mature
3. Researchers reveal insights into hidden world of protein folding
4. U of M researchers discover gene linked to adult-onset obesity
5. Livermore researchers use carbon nanotubes for molecular transport
6. UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system
7. Researchers observe spontaneous ratcheting of single ribosome molecules
8. At Boston symposium, NARSAD researchers report on genes and family traits
9. Fruits, vegetables and teas may protect smokers from lung cancer, UCLA researchers report
10. 2 University of Illinois researchers named HHMI investigators
11. New family of gecko discovered by researchers from the U of Minnesota and Villanova University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... Pa. , March 20, 2017 PMD ... 2.0 personal spirometer and Wellness Management System (WMS), a ... Founded in 2010, PMD Healthcare is a Medical ... with a mission dedicated to creating innovative solutions that ... life. With that intent focus, PMD developed the first ...
(Date:3/13/2017)... HAMBURG, Germany , March 13, 2017 Future of ... ... DERMALOGs Face Matching enables to match ... characteristics forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 ... and 23andMe , the leading personal genetics company, ... Zipongo can now provide customers with personalized nutrition plans ... and biometrics, but also genetic markers impacting how their ... Zipongo,s personalized food decision support platform uses biometrics such ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... PARK, Calif., March 23, 2017  BioPharmX Corporation ... products for the dermatology market, today reported financial ... 31, 2017, and will provide an update on ... the year. "We are pleased to ... year for BioPharmX," said President Anja Krammer. "We ...
(Date:3/23/2017)... 2017  Agriculture technology company Cool Planet has closed ... conversion to commercialize its Cool Terra and Cool Fauna ... products that are simultaneously profitable as well as sustainable ... 18 months. This latest round of funding was led ... The company,s primary product, Cool Terra, can ...
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma A/S ... innovative TransCon technology to address significant unmet medical ... for the full year ended December 31, 2016. ... for our company as we broadened our pipeline ... integrated rare disease company with an initial focus ...
(Date:3/22/2017)... , March 22, 2017 ... fragmented, states a research report by Transparency Market Research ... Inc., Amgen Inc., and AbbVie Inc., accounted for a ... The prominent players in this market are focusing aggressively ... product portfolio, which is likely to lead to market ...
Breaking Biology Technology: